This is a Study to Verify if Periarticular Hip Injection of Corticosteroid After Hip Replacement Reduce the Pain and the Hospitalisation Time

Recruiting Phase 4 Interventional Study
Femoral Neck Fractures
No Placebo Group Every participant receives an active treatment — no one gets a placebo. Prior Safety Data This treatment has already been tested in at least one earlier human trial.
Ready to participate?

Review the details below, then apply to join this clinical trial.

At a Glance
Age
50 – 90
Sex
Any
Trial phase
Phase 4
Study type
Interventional
Purpose
Treatment
Participants needed
110 (estimated)
Sponsor
Ente Ospedaliero Cantonale, Bellinzona · Other
Think this trial could be right for you?

Answer a few quick questions to see if you may meet the eligibility requirements.

Check Your Eligibility
About This Trial

The investigators are going to evaluate if periarticular corticosteroid injection during endoprothesis implantation can lead to any advantage to the patients, namely if it can reduce post-operative pain, lenght and cost of hospitalisation, use of analgesics drugs.

Trial Locations
Loading…

Loading trial locations…

Eligibility Criteria
Inclusion Criteria: * Patients undergoing unilateral cemented hip endoprosthesis for femoral neck fracture * Patients aged 50-90 years old * Patients with a BMI \>18.5 and \<35 * Patients able to provide informed consent and follow all the study procedures as indicated by the protocol * Informed Co…
Contacts

Christian MD Candrian, Prof.

0041918117029

Gabriela.Induni-Lang@eoc.ch

CONTACT

Gabriela Induni-Lang

0041918117029

Gabriela.Induni-Lang@eoc.ch

CONTACT